Skip to content
Recall Observatory FDA recall evidence

Drug product

Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister Cards each containing 28 tablets, 28 day regimen, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403 513, India, Manufactured for: Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430, NDC 68462-556-29

D-0588-2026

May 27, 2026

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 99101
Status
Ongoing
Classification
Class II
Quantity
Unavailable
Official record key
drug-enforcement:D-0588-2026

Official wording

Reason: Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.

Code information: Lot #: 20240411, Exp: 6/30/2026; 20250252, Exp: 3/31/2027

Distribution pattern: USA Nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out-of-specification